SORD Antibody

Sorbitol dehydrogenase (SORD) catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase, makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications (summarized by Carr and Markham, 1995 [PubMed 8535074]). The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor [taken from NCBI Entrez Gene (Gene ID: 6652)].
    Product Specifications
    Catalog # Size Price
    SORD AntibodyReactivity: Human
    Applications: IP
    Immunogen: Between 1 and 50
    A303-465A100 µl (1 mg/ml) $339Add to Cart
    A303-465A-T10 µl (1 mg/ml) $50Add to Cart
    SORD AntibodyReactivity: Human
    Applications: WB, IP
    Immunogen: Between 307 and 357
    A303-466A100 µl (0.2 mg/ml) $339Add to Cart
    A303-466A-M100 µl (10 blots) $229Add to Cart
    A303-466A-T20 µl (2 blots) $50Add to Cart
    Applications: WB, IP
    Reactivity: Human
    Includes: 1 each of A303-465A and A303-466A
    A311-278A1 Pack $472Add to Cart

    Please note that Cookies and JavaScript are required for you to view this website.

    Check if you have Cookies and JavaScript enabled in your browser